latest news releases from the newsroom
Sports Concepts, Inc
Motion DNA to Beef Up Its Management Team and to Seek Fully Reporting Status With an Investment Banker
SCOTTSDALE, Ariz., March 28, 2006 (PRIMEZONE) -- Zig Ziegler, Founder, CEO and President of Motion DNA Corporation (Pink Sheets:MTDX), announced today that he intends to step down. "As I have always promised to do whatever possible to enhance shareholder value of our Company's stock, I have decided to relegate myself the role of Director of Marketing and Technical Development and allow for the infusion of a powerful slate of officers and directors to continue to guide our Company thru the everyday operations and dealing with non-core corporate activities," stated Ziegler.
Nannaco Announces Agreement to Acquire Internet Based Radiation Oncology Treatment Planning Firm
GIG HARBOR, Wash., March 28, 2006 (PRIMEZONE) -- Nannaco, Inc. ("Nannaco") (Pink Sheets:NANN) announced today that on March 17, 2006, it entered into an agreement and Plan of Merger with GAK Acquisition Inc., which owns the right to acquire Comprehensive Physics & Rehabilitation Services ("CPRS"), a Nevada corporation. On the effective date of the merger, Nannaco will issue an amount of shares representing 95% of the issued and outstanding shares of Nannaco to the shareholders of GAK Acquisition, Inc. and will be allowed to elect one person to the Board of Directors.
Gardant Pharmaceuticals, Inc.
Bioaccelerate Announces Sale of Subsidiary and First Distribution
NEW YORK, March 28, 2006 (PRIMEZONE) -- Bioaccelerate Holdings, Inc (OTCBB:BACL), which has previously announced that it is changing its name to Gardant Pharmaceuticals, Inc., today announced the sale of its wholly owned subsidiary, Cain Biotech, Limited, to Accura Pharma PLC, a United Kingdom-based company. Accura Pharma PLC is a privately held company that is in the process of listing for trading on a public exchange in the United Kingdom. In exchange for its interest in Cain Biotech, Limited, Bioaccelerate Holdings, Inc. received at closing 120 million shares of the common stock of Accura Pharma PLC. Those shares constitute approximately 60% of the outstanding common stock of Accura Pharma PLC.
Everest Research Institute
Everest Research Institute Examines Offshore Adoption Trends in HR Outsourcing Market Update Report
NEW YORK and DALLAS, March 28, 2006 (PRIMEZONE) -- Human resources functions, led by benefits, payroll, employee data management and HR information technology, are increasingly moving offshore, according to Everest Research Institute's HRO Market Update -- Offshore Adoption. The new report, which focuses on offshore adoption trends among buyers and suppliers of HR outsourcing services, found that almost half (44 percent) of the more than 70 major HRO transactions currently in force have an offshore component. This number is expected to increase as HRO suppliers continue to invest in their offshore capabilities.
Atlanta's Uptown Square Apartments Now Leasing
ATLANTA, March 28, 2006 (PRIMEZONE) -- Buckhead's new Uptown Square Apartments, which have attracted positive attention from Atlanta to Washington, D.C., have something few other communities can offer: a MARTA rail station in its own backyard. This means it's now possible to walk out your door and arrive at the office, restaurant or store of your choice within minutes -- without fighting Atlanta traffic.
First Equity Group
StockMarketNewsAlert.com Introduces Infinity Mining Corp.
DEERFIELD BEACH, Fla., March 28, 2006 (PRIMEZONE) -- Infinity Mining Corp. (Pink Sheets:IFYMF) is new to StockMarketNewsAlert.com. According to D. Baker at First Equity Group, Inc., "Recent news flow from the company has been very positive." Baker announced today, "In its ongoing effort to achieve trading status on the Bulletin Board as well as other Exchanges, Infinity Mining Corp. has received and is responding to an inquiry from NASD for further information from the company, as part of their qualifying process."
Biogenerics Announces Update on Hydroslotter's California Project
TORONTO, March 28, 2006 (PRIMEZONE) -- Biogenerics Limited's (Pink Sheets:BIGN) strategic alliance partner, Hydroslotter Corporation, is pleased to announce that it has completed its preliminary valuation of the initial Grimes well, which revealed a commercially viable source of natural gas. Accordingly, Hydroslotter Corporation is endeavoring to link the Grimes source to commercial pipelines by April 1st, 2006. Please be advised that the flow rates for the initial Grimes well will be announced shortly hereafter.